Dermatology OTC Medications Market Revenue to Cross US$ 15,456.63 million by 2028 : Premium Market Insights

Dermatology OTC Medications Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Tablets and Capsules, Gels, Creams and Ointments, and Others), Route of Administration (Topical and Oral), Indication (Dermatitis, Acne, Psoriasis, Skin Bleaching, Fungal Disease, Warts, and Others), and Distribution Channel (Online Distribution and Offline Distribution) The dermatology OTC medications market is expected to grow from US$ 15,456.63 million in 2021 to US$ 21,313.40 million by 2028; it is estimated to grow at a CAGR of 4.7% from 2021 to 2028.

Get PDF Sample Report + All Related Table and Graphs @: https://www.premiummarketinsights.com/sample/TIP00073400?utm_source=OpenPR&utm_medium=10823

Competitive Landscape: Dermatology OTC Medications Market:
The high prevalence of skin problems and rising income of middle-class population are expected to boost the global market growth. However, the inappropriate use of OTC medications is restraining the growth of market.The COVID-19 pandemic has been adversely affecting several businesses across global. The supply chain disruptions and the huge demand for efficient treatments of COVID-19 have critically impacted the healthcare research industry in China. Prohibitive measures have been taken to resist the spread of the COVID-19 pandemic. The pandemic is expected to impact the dermatology OTC medications market significantly. For instance, India's manufacturers rely heavily on imports of their APIs from China. The lockdown has slowed the production of APIs, resulting in less availability and higher costs for the materials required for the products. Owing to the high demand for essential OTC drugs, the government has restricted the export of a few essential medicines. Due to the countrywide lockdown, the traditional supply chain of OTC drugs is facing several challenges. Many of these drugs are not available. Even after the specific guidelines and support of the state government to transport the essential OTC drugs, many retail pharmacies are experiencing a shortage of stock. On the other hand, the online purchase of OTC drugs has increased.

Bausch Health Companies Inc.
Perrigo Company plc
Bayer AG
Viatris Inc.
Johnson and Johnson Services, Inc.
LEO Pharma A/S
GlaxoSmithKline plc.
Galderma
Dr. Reddy's Laboratories
Acella Pharmaceuticals, LLC

Chapter Details of Dermatology OTC Medications Market:
Part 01: Executive Summary
Part 02: Scope of The Report
Part 03: Dermatology OTC Medications Market Landscape
Part 04: Dermatology OTC Medications Market Sizing
Part 05: Dermatology OTC Medications Market Segmentation by Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis

Interested in Purchasing this Report? Click here @ https://www.premiummarketinsights.com/buy/TIP00073400?utm_source=OpenPR&utm_medium=10823

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Ankit Mathur
E-mail: sales@permiummarketinsights.com
Phone: +1-646-491-9876

About Us:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.

This release was published on openPR.